Eckert & Ziegler subsidiary IBt Bebig acquires specialist for medical planning software

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Acquisition/Mergers & Acquisitions
Eckert & Ziegler subsidiary IBt Bebig acquires specialist for medical planning software

27.12.2010 / 18:07

Berlin, December 27, 2010 - IBt Bebig, a subsidiary of Eckert & Ziegler AG (ISIN DE0005659700) and a leading manufacturer of cancer radiation technology has absorbed all the shares in Bavarian SonoTech GmbH, a minor software developer which has specialised in the planning of radiation therapy.

The company positioned in Neu-Ulm, developed, among others, the software for the use of implants which IBt Bebig has in its range for the treatment of carcinoma of the prostatic gland. Furthermore, the company develops software to plan radiation therapy for the devices used for tumour radiation therapy of IBt Bebig, which are already being used on a broad scale and highly successfully by clinics and radiotherapists throughout the world.

'By the acquisition and the integration of SonoTech we are increasing our share in the value chain for the treatment of prostate cancer and other tumours', as Dr. Edgar Löffler, Member of the Board of Eckert & Ziegler AG and responsible for the segment Therapy explained. 'Our additional benefit is the possibility to further develop software in line with our own ideas. We are certainly most pleased that this step has led us to being able to bind the experienced software developers of SonoTech to our Group and are sure this will considerably enhance our competitive standing.'
The Eckert & Ziegler Group is a specialist for technical isotopic components used in radiation therapy and nuclear medicine. The Group has 540 employees on its payroll throughout the world and is one of the major suppliers of implants for prostate cancer treatment in Europe.
The Board of Directors


End of Corporate News


27.12.2010 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------

Language: English Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Deutschland Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: karolin.riehle@ezag.de Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, München  
 
End of News    DGAP News-Service  
--------------------------------------------------------------------- 107716 27.12.2010